Post by Cytiva

The body has the potential to become the place where therapies are created, not just delivered.​ This shift points to a new way of thinking about how medicines are developed. It moves away from complex external manufacturing and toward enabling therapies to be created within the patient.​ As genomic medicine advances, expanding access to the therapeutic toolbox for developers, clinicians, and patients will be key.​ What role do you see in vivo approaches playing in that future?​ 🎥 Watch "Episode 1: The vision" – part of our "The body as a bioreactor" video series – via the link in the comments. #GenomicMedicine #InVivo #Biotechnology #Innovation